FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1700090840> ?p ?o ?g. }

• W1700090840 abstract "Background Because spontaneous (non‐traumatic) intracerebral haemorrhage (ICH) volume influences its outcome and a third of ICHs enlarge by a third within 24 hours of onset, early haemostatic drug therapy might improve outcome. This is an update of a Cochrane review first published in 2006. Objectives To examine the clinical effectiveness and safety of haemostatic drug therapies for acute ICH in a randomised controlled trial (RCT) design. Search methods I searched the Cochrane Stroke Group Trials Register (last searched 26 June 2009), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2009), MEDLINE (1966 to June 2009) and EMBASE (1980 to June 2009). In an effort to identify further published, ongoing and unpublished studies I scanned bibliographies of relevant articles, searched international registers of clinical trials and research, and contacted authors and pharmaceutical companies. Selection criteria I sought RCTs of any haemostatic drug therapy for acute ICH, compared against placebo or open control, with relevant clinical outcome measures. Data collection and analysis Two authors independently applied the inclusion criteria, reviewed the relevant studies, and extracted data. Main results I found five phase II RCTs and one phase III RCT, involving 1398 adults aged 18 years or over, within four hours of ICH onset: 423 participants received placebo and 975 participants received haemostatic drugs (two received epsilon‐aminocaproic acid (EACA) and 973 received recombinant activated factor VII (rFVIIa)). Haemostatic drugs did not significantly reduce 90‐day case fatality after ICH (risk ratio (RR) 0.85, 95% confidence interval (CI) 0.58 to 1.25), and rFVIIa did not significantly reduce death or dependence on the modified Rankin Scale (grades 4 to 6) within 90 days of ICH (RR 0.91, 95% CI 0.72 to 1.15). There was a trend towards more participants on rFVIIa experiencing thromboembolic serious adverse events (RR 1.37, 95% CI 0.74 to 2.55) Authors' conclusions Haemostatic drugs cannot be recommended for the treatment of acute spontaneous ICH in clinical practice, but a large RCT would be justified." @default.
• W1700090840 created "2016-06-24" @default.
• W1700090840 creator A5034088593 @default.
• W1700090840 creator A5048743789 @default.
• W1700090840 creator A5051469085 @default.
• W1700090840 creator A5057794391 @default.
• W1700090840 creator A5079967649 @default.
• W1700090840 date "2009-10-07" @default.
• W1700090840 modified "2023-10-17" @default.
• W1700090840 title "Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage" @default.
• W1700090840 cites W1563680939 @default.
• W1700090840 cites W1822991619 @default.
• W1700090840 cites W1858061569 @default.
• W1700090840 cites W1888319739 @default.
• W1700090840 cites W1993543581 @default.
• W1700090840 cites W2004602863 @default.
• W1700090840 cites W2009791507 @default.
• W1700090840 cites W2011221519 @default.
• W1700090840 cites W2035028304 @default.
• W1700090840 cites W2043800309 @default.
• W1700090840 cites W2052174547 @default.
• W1700090840 cites W2054297863 @default.
• W1700090840 cites W2060002332 @default.
• W1700090840 cites W2065550131 @default.
• W1700090840 cites W2070507194 @default.
• W1700090840 cites W2084576139 @default.
• W1700090840 cites W2085403832 @default.
• W1700090840 cites W2094585602 @default.
• W1700090840 cites W2108361166 @default.
• W1700090840 cites W2117734296 @default.
• W1700090840 cites W2128178138 @default.
• W1700090840 cites W2142640478 @default.
• W1700090840 cites W2169423935 @default.
• W1700090840 cites W2178033301 @default.
• W1700090840 cites W2312654759 @default.
• W1700090840 cites W2409507474 @default.
• W1700090840 cites W4235543847 @default.
• W1700090840 cites W4238103798 @default.
• W1700090840 cites W4243451814 @default.
• W1700090840 cites W4249252758 @default.
• W1700090840 cites W4249987133 @default.
• W1700090840 doi "https://doi.org/10.1002/14651858.cd005951.pub3" @default.
• W1700090840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6494564" @default.
• W1700090840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29664991" @default.
• W1700090840 hasPublicationYear "2009" @default.
• W1700090840 type Work @default.
• W1700090840 sameAs 1700090840 @default.
• W1700090840 citedByCount "40" @default.
• W1700090840 countsByYear W17000908402012 @default.
• W1700090840 countsByYear W17000908402013 @default.
• W1700090840 countsByYear W17000908402014 @default.
• W1700090840 countsByYear W17000908402016 @default.
• W1700090840 countsByYear W17000908402017 @default.
• W1700090840 countsByYear W17000908402018 @default.
• W1700090840 countsByYear W17000908402019 @default.
• W1700090840 countsByYear W17000908402020 @default.
• W1700090840 countsByYear W17000908402021 @default.
• W1700090840 countsByYear W17000908402022 @default.
• W1700090840 countsByYear W17000908402023 @default.
• W1700090840 crossrefType "journal-article" @default.
• W1700090840 hasAuthorship W1700090840A5034088593 @default.
• W1700090840 hasAuthorship W1700090840A5048743789 @default.
• W1700090840 hasAuthorship W1700090840A5051469085 @default.
• W1700090840 hasAuthorship W1700090840A5057794391 @default.
• W1700090840 hasAuthorship W1700090840A5079967649 @default.
• W1700090840 hasConcept C107130276 @default.
• W1700090840 hasConcept C126322002 @default.
• W1700090840 hasConcept C127413603 @default.
• W1700090840 hasConcept C142724271 @default.
• W1700090840 hasConcept C168563851 @default.
• W1700090840 hasConcept C17744445 @default.
• W1700090840 hasConcept C187316915 @default.
• W1700090840 hasConcept C199539241 @default.
• W1700090840 hasConcept C204787440 @default.
• W1700090840 hasConcept C27081682 @default.
• W1700090840 hasConcept C2771230 @default.
• W1700090840 hasConcept C2776478404 @default.
• W1700090840 hasConcept C2777094939 @default.
• W1700090840 hasConcept C2777736543 @default.
• W1700090840 hasConcept C2779473830 @default.
• W1700090840 hasConcept C2780645631 @default.
• W1700090840 hasConcept C44249647 @default.
• W1700090840 hasConcept C535046627 @default.
• W1700090840 hasConcept C71924100 @default.
• W1700090840 hasConcept C78519656 @default.
• W1700090840 hasConcept C82789193 @default.
• W1700090840 hasConcept C95190672 @default.
• W1700090840 hasConceptScore W1700090840C107130276 @default.
• W1700090840 hasConceptScore W1700090840C126322002 @default.
• W1700090840 hasConceptScore W1700090840C127413603 @default.
• W1700090840 hasConceptScore W1700090840C142724271 @default.
• W1700090840 hasConceptScore W1700090840C168563851 @default.
• W1700090840 hasConceptScore W1700090840C17744445 @default.
• W1700090840 hasConceptScore W1700090840C187316915 @default.
• W1700090840 hasConceptScore W1700090840C199539241 @default.
• W1700090840 hasConceptScore W1700090840C204787440 @default.
• W1700090840 hasConceptScore W1700090840C27081682 @default.
• W1700090840 hasConceptScore W1700090840C2771230 @default.
• W1700090840 hasConceptScore W1700090840C2776478404 @default.
• W1700090840 hasConceptScore W1700090840C2777094939 @default.

• next